Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2015, Vol. 42 Issue (1): 49-52    DOI: 10.12891/ceog1904.2015
Original Research Previous articles | Next articles
How does early cognitive behavioural therapy reduce postpartum depression?
G. Carta1, A. D’Alfonso1, V. Parisse1, A. Di Fonso1, M. Casacchia1, F. Patacchiola1, *()
1Department of Life, Health & Environmental Sciences, University of L’Aquila, L’Aquila (Italy)
Download:  PDF(148KB)  ( 30 )
Export:  BibTeX | EndNote (RIS)      
Abstract  Postpartum depression (PPD) is a frequent mood disorder. Early identification of mothers at risk is crucial to successful prevention.Cognitive Behavioural Therapy (CBT) is an effective preventing therapy. Objectives of this study are to identify mothers at risk for PPDusing the Edinburgh Postnatal Depression Scale (EPDS) and evaluate the efficacy of CBT for the prevention of PPD in these mothers.Women were recruited during their second postpartum day. Two groups were selected: mothers with high risk (EPDS score ≥ 10) andmothers with low risk (EPDS score <10) of PPD. The first group underwent CBT. Follow up was carried out at 40 days, three, six, and12 months after childbirth. APGAR score, neonatal hospitalization, delayed breastfeeding, and cesarean section were significant obstetricrisk factors. Mothers at high risk of PPD presented a statistically valid improvement of EPDS score. Mothers with low risk of PPD didnot have CBT and showed a higher EPDS score than mother at high risk at 12 months. PPD prevention is possible through early identificationof mothers at risk and early cognitive behavioural therapy.
Key words:  Postpartum depression      Cognitive behavioural therapy      Prevention      Risk factors      Edinburgh Postnatal Depression Scale     
Published:  10 February 2015     
*Corresponding Author(s):  F. Patacchiola     E-mail:  felice.patacchiola@libero.it

Cite this article: 

G. Carta, A. D’Alfonso, V. Parisse, A. Di Fonso, M. Casacchia, F. Patacchiola. How does early cognitive behavioural therapy reduce postpartum depression?. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(1): 49-52.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog1904.2015     OR     https://ceog.imrpress.com/EN/Y2015/V42/I1/49

[1] Iulia Baciu, Dalila-Ana Domuncu, Tiberiu Domuncu, Anca Marina Ciobanu, Theodor Voiosu, Gheorghe Peltecu, Anca Maria Panaitescu. Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 9-18.
[2] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[3] Li Li Zhang, Hua Shu, Shuai Zhang, Tian Tian Wang, Lan Lan Zhang. Pregnancy outcomes and risk factors in pregnant women with systemic lupus erythematosus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 189-193.
[4] T. T. Kitova, B. D. Kitov, E. H. Uchikova, N. T. Ahmad. Maternal age - a risk factor for congenital hydrocephalus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 257-261.
[5] S.M.S. Fernandes, J.C.L. Ribalta, N.M.G. Speck, Y. Yamamura. Treatment of uterine cervical ectopy with acupuncture and analysis of risk factors in the metaplastic process[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 601-605.
[6] A. Średniawa, K. Kruk, D. Ł. Jarczewska, K. Żabicka, M. Golonka, R. Krępa, T. Tomasik. Postpartum depression and breastfeeding in primary care in Krakow, Poland[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 880-885.
[7] M. Li, L. Riming, W. Zhe, W. Hong, H. Xiaofei, C. Lina, Z. Zhengfang, W. Xuebo, W. Ning, S. Chengming, H. Qing-qing, L. Hailiang, W. Hui. Non-invasive prenatal screening for chromosome 21, 18, and 13 aneuploidies in a mixed risk factors pregnancy population[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 523-528.
[8] E. Djakovic, S. Rakic. Depression, anxiety, and stress after preterm delivery: role of previous progesterone therapy[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 214-217.
[9] F.Q. Ma, G.Y. Zhang, J.B. Gao, C. Fang, Y. Bo, G.Y. Huang, A.H. Zhang. Clinical screening method and risk factors’ analysis of congenital cardiovascular defects: a case control study from a Chinese local region[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 515-520.
[10] H.A. Inal, Z.H. Ozturk Inal, N. Yilmaz, H. Timur, A.S. Oruc, M.N. Kalem, O. Han. The effects of formoterol on the serum, peritoneal VEGF, MDA, and VEGF levels in the ovaries and endometrium of rats with OHSS[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 122-128.
[11] G. Özakşit, A. Tokmak, H. Kalkan, E. Sarıkaya. Is there an association between serum vitamin D levels and endometrial polyps?[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 539-543.
[12] P. Albers-Heitner, L. Bekkers, H. Moossdorff, B. Berghmans, P. Verdonk. Is urinary incontinence during and after pregnancy related to family history? A web-based survey among postpartum women (motherfit project)[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(2): 203-208.
[13] G. Batmaz, B. Dane, A. Sarioglu, Z. Kayaoglu, C. Dane. Can we predict postpartum depression in pregnant women?[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(5): 605-609.
[14] Y. Yuan, W. Zhou, X. Rong, W.N. Lu, Z. Zhang. Incidence and factors associated with nosocomial infections in a neonatal intensive care unit (NICU) of an urban children’s hospital in China[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(5): 619-628.
[15] H.D. Alebous, M.E. Ma’aita, F.A. Alkhazaleh. Folic acid and neural tube defects: are Jordanian pregnant women aware?[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(6): 647-653.
No Suggested Reading articles found!